Frank‐Peter Theil

4.4k total citations
39 papers, 3.2k citations indexed

About

Frank‐Peter Theil is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Frank‐Peter Theil has authored 39 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Frank‐Peter Theil's work include Pharmacogenetics and Drug Metabolism (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Computational Drug Discovery Methods (8 papers). Frank‐Peter Theil is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Computational Drug Discovery Methods (8 papers). Frank‐Peter Theil collaborates with scholars based in United States, Switzerland and Belgium. Frank‐Peter Theil's co-authors include Patrick Poulin, Paul J. Fielder, Leslie A. Khawli, C. Andrew Boswell, Saileta Prabhu, Rong Deng, Devin B. Tesar, Kiran Mukhyala, Suhasini Iyer and Theodor W. Guentert and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Frank‐Peter Theil

39 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank‐Peter Theil United States	25	1.2k	1.0k	996	853	400	39	3.2k
Hannah M. Jones United States	36	1.1k 1.0×	1.3k 1.2×	262 0.3×	1.4k 1.6×	493 1.2×	105	3.8k
Thierry Lavé Switzerland	35	682 0.6×	1.1k 1.1×	140 0.1×	1.3k 1.5×	485 1.2×	68	3.0k
Christopher R. Gibson United States	17	418 0.4×	558 0.5×	197 0.2×	731 0.9×	273 0.7×	44	1.7k
Nigel J. Waters United States	26	2.0k 1.7×	499 0.5×	143 0.1×	555 0.7×	476 1.2×	58	3.2k
Russell Weiner United States	21	1.3k 1.1×	513 0.5×	556 0.6×	148 0.2×	105 0.3×	40	3.7k
Tycho Heimbach United States	28	1.1k 0.9×	618 0.6×	86 0.1×	613 0.7×	295 0.7×	70	3.4k
Jan Snoeys Belgium	33	1.2k 1.1×	897 0.9×	97 0.1×	906 1.1×	194 0.5×	94	3.7k
Joseph E. Tomaszewski United States	36	2.4k 2.0×	1.5k 1.5×	183 0.2×	243 0.3×	178 0.4×	140	4.6k
J. Gerry Kenna United Kingdom	33	976 0.8×	948 0.9×	99 0.1×	1.8k 2.1×	392 1.0×	88	3.9k
Jerome Hochman United States	30	1.0k 0.9×	1.0k 1.0×	233 0.2×	618 0.7×	169 0.4×	44	2.6k

Countries citing papers authored by Frank‐Peter Theil

Since Specialization

Citations

This map shows the geographic impact of Frank‐Peter Theil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank‐Peter Theil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank‐Peter Theil more than expected).

Fields of papers citing papers by Frank‐Peter Theil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank‐Peter Theil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank‐Peter Theil. The network helps show where Frank‐Peter Theil may publish in the future.

Co-authorship network of co-authors of Frank‐Peter Theil

This figure shows the co-authorship network connecting the top 25 collaborators of Frank‐Peter Theil. A scholar is included among the top collaborators of Frank‐Peter Theil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank‐Peter Theil. Frank‐Peter Theil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumann, Andreas, Kelly M. Flagella, Roy Forster, et al.. (2014). New challenges and opportunities in nonclinical safety testing of biologics. Regulatory Toxicology and Pharmacology. 69(2). 226–233. 19 indexed citations

Poulin, Patrick, Donna M. Dambach, Kevin A. Ford, et al.. (2013). An Algorithm for Evaluating Potential Tissue Drug Distribution in Toxicology Studies from Readily Available Pharmacokinetic Parameters. Journal of Pharmaceutical Sciences. 102(10). 3816–3829. 9 indexed citations

Wong, Harvey, Edna F. Choo, Bruno Alicke, et al.. (2012). Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response. Clinical Cancer Research. 18(14). 3846–3855. 96 indexed citations

Deng, Rong, Y. Gloria Meng, Kwame Hoyte, et al.. (2012). Subcutaneous bioavailability of therapeutic antibodies as a function  of FcRn binding affinity in mice. mAbs. 4(1). 101–109. 66 indexed citations

Yan, Xin, Shuang Bai, Lisa A. Damico‐Beyer, et al.. (2012). Anti-Neuropilin-1 (MNRP1685A): Unexpected Pharmacokinetic Differences Across Species, from Preclinical Models to Humans. Pharmaceutical Research. 29(9). 2512–2521. 25 indexed citations

Boswell, C. Andrew, Gregory Z. Ferl, Eduardo E. Mundo, et al.. (2011). Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow. PLoS ONE. 6(3). e17874–e17874. 28 indexed citations

Bumbaca, Daniela, Hong Xiang, C. Andrew Boswell, et al.. (2011). Maximizing tumour exposure to anti‐neuropilin‐1 antibody requires saturation of non‐tumour tissue antigenic sinks in mice. British Journal of Pharmacology. 166(1). 368–377. 33 indexed citations

Richter, W., Hans Peter Grimm, & Frank‐Peter Theil. (2011). Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components. Journal of Pharmacokinetics and Pharmacodynamics. 38(5). 581–593. 2 indexed citations

Wong, Harvey, Sock-Cheng Lewin-Koh, Frank‐Peter Theil, & Cornelis E. C. A. Hop. (2011). Influence of the Compound Selection Process on the Performance of Human Clearance Prediction Methods. Journal of Pharmaceutical Sciences. 101(2). 509–515. 4 indexed citations

10.

Wong, Harvey, Frank‐Peter Theil, Yong Cui, et al.. (2010). Interplay of Dissolution, Solubility, and Nonsink Permeation Determines the Oral Absorption of the Hedgehog Pathway Inhibitor GDC-0449 in Dogs: An Investigation Using Preclinical Studies and Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition. 38(7). 1029–1038. 17 indexed citations

11.

Poulin, Patrick, Sean Ekins, & Frank‐Peter Theil. (2010). A hybrid approach to advancing quantitative prediction of tissue distribution of basic drugs in human. Toxicology and Applied Pharmacology. 250(2). 194–212. 30 indexed citations

12.

Deng, Rong, Kelly M. Loyet, Samantha Lien, et al.. (2010). Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys. Drug Metabolism and Disposition. 38(4). 600–605. 92 indexed citations

13.

Poulin, Patrick & Frank‐Peter Theil. (2009). Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. Journal of Pharmaceutical Sciences. 98(12). 4941–4961. 99 indexed citations

14.

Edginton, Andrea N., Frank‐Peter Theil, Walter Schmitt, & Stefan Willmann. (2008). Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opinion on Drug Metabolism & Toxicology. 4(9). 1143–1152. 121 indexed citations

15.

Luttringer, Olivier, Frank‐Peter Theil, Patrick Poulin, et al.. (2003). Physiologically Based Pharmacokinetic (PBPK) Modeling of Disposition of Epiroprim in Humans. Journal of Pharmaceutical Sciences. 92(10). 1990–2007. 55 indexed citations

16.

Lavé, Thierry, et al.. (2002). Prediction of Human Pharmacokinetics Based on Preclinical In Vitro and In Vivo Data. PubMed. 81–104. 2 indexed citations

17.

Poulin, Patrick & Frank‐Peter Theil. (2002). Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism‐Based Prediction of Volume of Distribution. Journal of Pharmaceutical Sciences. 91(1). 129–156. 438 indexed citations

18.

Poulin, Patrick & Frank‐Peter Theil. (2002). Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug Disposition. Journal of Pharmaceutical Sciences. 91(5). 1358–1370. 225 indexed citations

19.

Poulin, Patrick, et al.. (2001). Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs. Journal of Pharmaceutical Sciences. 90(4). 436–447. 162 indexed citations

20.

Hubschwerlen, Christian, et al.. (1998). Synthesis, physicochemical and pharmacokinetic properties of water soluble prodrugs of Ro 63-9141/000. 38. 239. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact